Venrock Healthcare Capital Partners portfolio
34 tracked investments, 6 on the map, $2.1B raised across the mapped portfolio.
Venrock Healthcare Capital Partners34 investments · 6 on the map · $2.1B raised- Ocular Therapeutix
- Mineralys TherapeuticsPost-IPO Equity
- Artiva BiotherapeuticsSeries B
- ADARx Pharmaceuticals
- Tenaya Therapeutics
- Lycia Therapeutics
Also in the portfolio
- Tubulis
- Maze Therapeutics
- Apogee Therapeutics
- Oruka Therapeutics
- enGene
- Abivax
- Terns Pharmaceuticals
- Korro Bio
- Dianthus Therapeutics
- Angitia Biopharmaceuticals
- Upstream Bio
- Enliven Therapeutics
- AIRNA
- Centessa Pharmaceuticals
- Carmot Therapeutics
- ORIC Pharmaceuticals
- Cidara Therapeutics
- Surrozen
- Lyra Therapeutics
- Avadel Pharmaceuticals
- LianBio
- Cullinan Therapeutics
- Taysha Gene Therapies
- Pharvaris
- Kiniksa Pharmaceuticals
- CASI Pharmaceuticals
- Surface Oncology
Investors similar to Venrock Healthcare Capital Partners
RA Capital Management150 investments · 92 on the map · $6.7B raised
Franklin Templeton113 investments · 17 on the map · $9.6B raised
Redmile Group61 investments · 14 on the map · $5.4B raised
Cormorant Asset Management67 investments · 11 on the map · $3.1B raised
HBM Healthcare Investments56 investments · 10 on the map · $3.4B raised
TCG Crossover27 investments · 9 on the map · $4.1B raised